￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Interpretation of the latest conditions for medical insurance reimbursement of Ribociclib/Ribociclib

2026-02-01 22:25:32

Check Details
Efficacy evaluation and side effects of cimepilimab

2026-02-01 22:25:32

Check Details
Comparative analysis of valumab and Infinifer 500mg in 2025

2026-02-01 22:25:32

Check Details
Is genetic testing necessary before zotuximab treatment? Can the testing costs be reimbursed?

2026-02-01 22:25:32

Check Details
Can margituximab be used in combination with immunotherapy (such as PD-1)?

2026-02-01 22:25:32

Check Details
What are the relevant information and characteristics of the Lao version of Avonib?

2026-02-01 22:25:32

Check Details
Common side effects of mitotane and what issues should be paid attention to during use

2026-02-01 22:25:32

Check Details
Does pemetinib/pemetinib need to be taken for a long time and can it be stopped?

2026-02-01 22:25:32

Check Details
Is erdafitinib currently on the market in China?

2026-02-01 22:25:32

Check Details
Chinese instructions for the targeted drug Pralsetinib

2026-02-01 22:25:32

Check Details
Can treatment be interrupted after taking capmatinib?

2026-02-01 22:25:32

Check Details
Is the domestically produced sotorasiib targeted drug already on the market?

2026-02-01 22:25:32

Check Details
Category
相关知识